Palantir Technologies (PLTR) recently experienced significant developments, such as entering into a partnership with Unstructured via its FedStart program to expedite compliance processes for ...

Palantir Technologies ($PLTR) recently reached a new 52-week high as investor enthusiasm soared after the company’s blowout Q2 results.

National Health Investors combines solid income, FFO growth, and improving fundamentals, backed by strong margins and ...

Palantir is still one of Wood’s top bets after recent sales. The stock is now the seventh biggest holding of the ARK ...

Rep. Marjorie Taylor Greene (R-Ga.)'s investment in Palantir has seen an impressive surge of 142% since April.

Detailed price information for Crispr Therapeutics Ag (CRSP-Q) from The Globe and Mail including charting and trades.